| __timestamp | Amicus Therapeutics, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 246000000 |
| Thursday, January 1, 2015 | 76943000 | 582800000 |
| Friday, January 1, 2016 | 104793000 | 455000000 |
| Sunday, January 1, 2017 | 149310000 | 366000000 |
| Monday, January 1, 2018 | 270902000 | 414000000 |
| Tuesday, January 1, 2019 | 286378000 | 471000000 |
| Wednesday, January 1, 2020 | 308443000 | 452000000 |
| Friday, January 1, 2021 | 272049000 | 465000000 |
| Saturday, January 1, 2022 | 276677000 | 529000000 |
| Sunday, January 1, 2023 | 152381000 | 604000000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Amicus Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Bausch Health consistently allocated a significant portion of its resources to R&D, peaking in 2023 with a 146% increase from its 2014 spending. In contrast, Amicus Therapeutics showed a more volatile pattern, with a notable surge in 2020, reaching its highest R&D expenditure, before a sharp decline in 2023. This divergence highlights Bausch Health's steady commitment to innovation, while Amicus Therapeutics appears to be recalibrating its strategic focus. As the pharmaceutical industry evolves, these spending patterns may offer insights into each company's future trajectory and market positioning.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Bausch Health Companies Inc.
Verona Pharma plc or Bausch Health Companies Inc.: Who Invests More in Innovation?
R&D Insights: How Verona Pharma plc and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Viridian Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.